ID: ALA1630015

Max Phase: Preclinical

Molecular Formula: C17H36O3

Molecular Weight: 288.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCC(O)CCCC[C@@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C17H36O3/c1-3-4-5-6-7-8-9-12-16(19)13-10-11-14-17(20)15(2)18/h15-20H,3-14H2,1-2H3/t15-,16?,17+/m0/s1

Standard InChI Key:  HNHGHXXVZPJPCT-RPCGPGEBSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 288.47Molecular Weight (Monoisotopic): 288.2664AlogP: 3.79#Rotatable Bonds: 14
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.43Np Likeness Score: 1.16

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source